X-BIOCELL LTD

Active Cambridge

Research and experimental development on biotechnology

4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
X

X-BIOCELL LTD

Research and experimental development on biotechnology

Founded 29 Mar 2010 Active Cambridge, England 4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 27 Oct 2025 Next due 31 Oct 2026 6 months remaining
Confirmation Submitted 16 Jan 2026 Next due 29 Jan 2027 9 months remaining
Net assets £-52K £2K 2024 year on year
Total assets £811 £64 2024 year on year
Total Liabilities £53K £2K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

208 Mill Road Cambridge CB1 3NF England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for X-BIOCELL LTD (07207119), an active life sciences and medical technology company based in Cambridge, England. Incorporated 29 Mar 2010. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

-£52.45k

Decreased by £1.85k (-4%)

Total Liabilities

£53.27k

Increased by £1.91k (+4%)

Turnover

N/A

Employees

4

Debt Ratio

6568%

Decreased by 307 (-4%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 80 Shares £80 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
14 Jan 202680£80£1

Officers

Officers

1 active 2 resigned
Status
Andrew JacksonDirectorBritishUnited Kingdom5929 Mar 2010Active

Shareholders

Shareholders (6)

Andrey Tikhonov
24.0%
91
Alexei Alexandroff
17.9%
68

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Alexei Veniamin Alexandroff

British

Active
Notified 6 Apr 2016
Residence England
DOB January 1963
Nature of Control
  • Significant Influence Or Control,significant Influence Or Control As Trust,significant Influence Or Control As Firm

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Feb 2026Persons With Significant ControlNotification of a person with significant control statement
16 Jan 2026CapitalAllotment of shares (GBP 379) on 14 Jan 2026
16 Jan 2026Confirmation StatementConfirmation statement made on 15 Jan 2026 with updates
14 Jan 2026Persons With Significant ControlCessation of Alexei Veniamin Alexandroff as a person with significant control on 14 Jan 2026
17 Nov 2025OfficersTermination of Andrey Tikhonov as director on 14 Nov 2025
18 Feb 2026 Persons With Significant Control

Notification of a person with significant control statement

16 Jan 2026 Capital

Allotment of shares (GBP 379) on 14 Jan 2026

16 Jan 2026 Confirmation Statement

Confirmation statement made on 15 Jan 2026 with updates

14 Jan 2026 Persons With Significant Control

Cessation of Alexei Veniamin Alexandroff as a person with significant control on 14 Jan 2026

17 Nov 2025 Officers

Termination of Andrey Tikhonov as director on 14 Nov 2025

Recent Activity

Latest Activity

Notification of a person with significant control statement

2 months ago on 18 Feb 2026

Allotment of shares (GBP 379) on 14 Jan 2026

3 months ago on 16 Jan 2026

Confirmation statement made on 15 Jan 2026 with updates

3 months ago on 16 Jan 2026

Cessation of Alexei Veniamin Alexandroff as a person with significant control on 14 Jan 2026

3 months ago on 14 Jan 2026

Termination of Andrey Tikhonov as director on 14 Nov 2025

5 months ago on 17 Nov 2025